EXHIBIT 4.5

            FORM OF SUBSCRIPTION AGREEMENTS DATED SEPTEMBER 21, 2005
       BETWEEN THE COMPANY AND EACH OF GLOBAL CHINA ENTERPRISES LIMITED,
        FIVESTAR INTERNATIONAL LIMITED, MART EXPRESS LIMITED, RICH GUSH
         LIMITED, MART BURKIT LIMITED AND SINO CASTLE HOLDINGS LIMITED
<PAGE>

                            SUBSCRIPTION OFFER LETTER



PRIVATE & CONFIDENTIAL

September 21, 2005

---------------------
---------------------
---------------------
---------------------
---------------------

Attention:
           -------------------

Dear Sirs,

CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION  (THE "COMPANY") -
PLACING OF 7,500,000 NEW SHARES (THE "SUBSCRIPTION SHARES")
IN THE ISSUED SHARE CAPITAL OF THE COMPANY AT US$0.01 PER SHARE (THE
"SUBSCRIPTION PRICE") (THE "SUBSCRIPTION")

1.       INTRODUCTION

         We refer to our conversation,  whereby we offered, subject to the terms
         and  conditions  set out below,  to procure  the sale to you  7,500,000
         shares at the Subscription Price of US$0.01 per Subscription Share (the
         "Subscription  Shares") for the total  subscription of US$75,000.00 and
         you orally  accepted our offer and agreed  irrevocably  as principal to
         purchase the Subscription Shares.

         All capitalized terms used, but not otherwise defined herein shall have
         the meanings set for on Appendix A attached hereto.


2.       CONDITIONS

         Please note that the  Subscription is conditional upon that immediately
upon signing hereof.


3.       SETTLEMENT DATE

         Settlement  is scheduled to take place on or before  September 28, 2005
(the "Settlement Date").

                                       1
<PAGE>



4.       AMOUNT PAYABLE

         The  total  amount  payable  by you for  your  Subscription  Shares  is
         US$75,000.00   (or  the   equivalent   amount  in   Renminbi  or  other
         currencies).


5.       NOT A US PERSON; NOT AN AFFILIATE

         Upon your  acceptance  hereto,  you shall confirm that you are not a US
         Person  and  confirm  that  in  relation  to your  subscription  of the
         Subscription  Shares, you or your beneficial owner are not an Affiliate
         of the Company nor any  directors,  executive  officers,  or Beneficial
         Owners  thereof  or a  member  of the  Shareholder  Group  thereof.  In
         addition,  you shall  declare that your  acceptance of our offer of the
         Subscription  Shares is entirely of your own  volition and that you are
         not acting  upon the  instruction  of any such  Affiliate.  Also,  your
         purchase  of the  Subscription  Shares  is  not  financed  directly  or
         indirectly by any such Affiliate.

6.       UNDERTAKINGS

         By your acceptance of our offer, you;

                  (a) agree to make payment of  US$75,000.00 in full for all the
                  Subscription  Shares by the Settlement Date, and that interest
                  of 2% p.a.  above the Hong Kong  prime rate will be payable on
                  any late settlement;

                  (b)  agree  that  you  have  not  relied  on any  information,
                  representation  or warranty  supplied or made by us or any one
                  on behalf of  ourselves  or any other  party  involved  in the
                  Subscription  and that you have made and will continue to make
                  your own appraisal of the  Subscription  and the  Subscription
                  Shares and the other matters referred to in this letter;

                  (c)  agree  and  acknowledge  that we do not make and have not
                  made any warranty,  representation or recommendation as to the
                  merits of the Subscription Shares;

                  (d) represent  and warrant to us that you or beneficial  owner
                  are not US  Person(s) or  Affiliate(s)  of the Company nor any
                  directors, executive officers, or Beneficial Owners thereof or
                  a member of a Shareholder Group thereof;

                  (e) represent  and warrant that you had at all material  times
                  and still  have full  power and  authority  to enter  into the
                  contract of the  Subscription  for your own account or for the
                  account  of  one  or  more   persons  for  whom  you  exercise
                  investment  discretion  and your  oral  agreement  to do so as
                  recorded  herein  constitutes  your valid and legally  binding
                  obligation and is enforceable in accordance with its terms.

         You will,  whether  before  or after  completion  of the  Subscription,
         continue to provide us information  regarding the  beneficial  owner of
         the  Subscription  Shares acquired by you as required by applicable BVI
         law and US laws for  delivery to the relevant  regulatory  authority or
         governmental agency.


                                       2
<PAGE>


         Information  and personal data provided by you to us are connected with
         the Subscription  and you shall observe any rules,  legal or regulatory
         requirements   including  the   disclosure  of  such  data  to  certain
         regulatory  bodies.  Also,  we may  provide  such  data  to any  agent,
         representative and associate, which provide services in connection with
         the Subscription.

7.       GENERAL

         Any  notification  to be given by us to you shall be  validly  given if
         delivered  by hand or sent by  facsimile  to the address and  facsimile
         numbers set out in the attached Subscription  Confirmation and shall be
         deemed  to be given on  delivery  or (if  given  by  facsimile)  on due
         despatch.

         Your  rights and  obligations  in respect of the  Subscription  will be
         incapable of rescission or  termination  by you. Time is of the essence
         of the Subscription.

         The  Subscription  recorded  in this  letter  shall be  governed by and
         construed in accordance  with the laws of Hong Kong and we respectively
         submit to the non-exclusive  jurisdiction of the courts of Hong Kong in
         respect thereof.

         NO AMENDMENT TO THE TERMS AND CONDITIONS OF THIS LETTER CAN BE ACCEPTED
         TO US.

8.       ACKNOWLEDGMENT

         Please complete and return the attached Subscription Confirmation  with
         the duplicate of this letter to the  undersigned at  Hong  Kong fax no.
         (852) 2851 3660.

Yours faithfully,
For and on behalf of
CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION





-------------------------------------
Zhou Li Yang
Executive Director and Chief Financial Officer

Encl.



                                       3
<PAGE>

                                                                    APPENDIX A

Capitalized  terms used,  but not otherwise  defined in the  Subscription  Offer
Letter shall have the meanings set forth below:

"AFFILIATE"              means a person that directly, or indirectly through one
                         or  more intermediaries, controls, or is controlled by,
                         or  is  under  common  control  with,  the  Company,  a
                         director an executive officer or a Beneficial Owner.

"BENEFICIAL OWNER"       means any person who directly  or   indirectly  is  the
                         beneficial owner of more than five percent  of a  class
                         of the Company's securities.

"SHAREHOLDER GROUP"      means two or more persons act as a partnership, limited
                         partnership, syndicate, or other group for the  purpose
                         of acquiring,  holding,  or disposing  of securities of
                         the Company;

"US PERSON"              means:

                           a.  Any natural person resident in the United States;

                           b.  Any  partnership   or  corporation  organized  or
                               incorporated under the laws of the United States;

                           c.  Any estate of which any executor or administrator
                               is a U.S. person;

                           d.  Any trust of which any  trustee is a U.S. person;

                           e.  Any agency or branch of a foreign entity located
                               in the United States;

                           f.  Any non-discretionary account or  similar account
                               (other  than an estate or trust) held by a dealer
                               or other fiduciary   for  the benefit  or account
                               of a  U.S. person;

                           g.  Any  discretionary  account  or  similar  account
                               (other  than an estate or trust) held by a dealer
                               or  other fiduciary   organized, incorporated, or
                               (if an individual) resident in the United States;
                               and

                           h.  Any partnership or corporation if:

                               (i)  Organized or incorporated  under the laws of
                                    any foreign jurisdiction; and

                               (ii) Formed  by a U.S. person principally for the
                                    purpose  of  investing  in  securities   not
                                    registered   under  the   Act, unless it  is
                                    organized  or  incorporated,  and owned,  by
                                    accredited  investors  (as  defined in  Rule
                                    501(a)) who are not natural persons, estates
                                    or trusts.


                                       4
<PAGE>


                            SUBSCRIPTION CONFIRMATION


-------------------------------------------------------------
PRIVATE & CONFIDENTIAL
-------------------------------------------------------------


September 21, 2005


To       :        China Pharmaceuticals International Corporation
                  Unit 3611, West Tower
                  Shun Tak Centre
                  Central, Hong Kong

Attn     :        Mr. Zhou Li Yang
                  Executive Director
                  (Fax No: 2851 3660)

Dear Sirs,

CHINA PHARMACEUTICALS INTERNATIONAL CORPORATION (THE "COMPANY") -
PLACING OF 7,500,000 NEW SHARES (THE "PLACING SHARES")
IN THE ISSUED SHARE CAPITAL OF THE COMPANY AT US$0.01 PER SHARE (THE "PLACING
PRICE") (THE "PLACING")

We refer to your  Subscription  Offer  Letter  dated  September  16,  2005  (the
"Subscription Offer Letter") in relation to the captioned subject. Terms used in
this letter shall have the same  meanings as defined in the  Subscription  Offer
Letter, unless the context requires otherwise.

We hereby confirm receipt of the Subscription  Offer Letter, and acknowledge and
accept all the terms and  conditions  as set out therein and confirm  that these
terms and conditions are those of our oral contract to your  representative  for
our/my  subscription  as principal  from the Company of  7,500,000  subscription
shares  (the  "Subscription  Shares") at the  Subscription  Price of US$0.01 per
share  for the  total  subscription  of  US$75,000.00  We  undertake  to pay the
consideration  for the  Subscription  Shares of  US$75,000.00  on or before  the
Settlement Date as set out in the  Subscription  Offer Letter by a cashier order
drawn on a licensed bank in Hong Kong or China.

Further more, we hereby confirm that: -

(1)   We undertake to provide to you upon request such other information  as may
      be required to be provided to the  Securities and Exchange Commission (the
      "SEC") and OTCBB;

(2)   We are not a US Person(s).  We are a private  investor whose main business
      involves the acquisition and disposal, or the holding, of shares and other
      securities as principal and the subscription of the Subscription Shares by
      us would not constitute a breach of the relevant laws;


                                       5
<PAGE>




(3)   We or our  beneficial  owner are not an  Affiliate  of the Company nor any
      directors, executive officers, or Beneficial Owners thereof or a member of
      a Shareholder Group thereof;

(4)   We are not financed or backed  directly or indirectly by the Company,  its
      directors,  its Beneficial  Owners or its executive officers or any of the
      Company's Affiliates;

(5)   We are not a person who is accustomed to taking  instructions  from any of
      the director,  executive  officers or Beneficial  Owners of the Company or
      any of their Affiliates in relation to the acquisition,  disposal,  voting
      or any other disposition of securities in the Company;

(6)   We  understand  that  information  and  personal  data  provided by us are
      required in relation to the Subscription  and to observe any rules,  legal
      or  regulatory  requirements  including  the  disclosure  of such  data to
      certain  regulatory  bodies.  Moreover,  we shall provide such data to any
      governmental or regulatory  bodies (including but not limited to the OTCBB
      and the SEC);

(7)   We undertake  to  respond promptly, in writing, to questions raised by you
      relating to the Subscription.

(8)   No share  of  the  Company was held by us prior to our  entering  into the
      agreement to participate as a subscriber in the Subscription;

(9)   In  case  of  a default in payment,  you shall reserve the right to charge
      interest  on  the  net  amount  overdue  calculated on the basis of 2% per
      month;

(10)  The details of the ULTIMATE BENEFICIAL OWNER(S) of the Subscription Shares
      subscribed through the Placing are as follows: -

      Name                        :
                                     -------------------------------

      Address                     :
                                     -------------------------------
                                     -------------------------------
                                     -------------------------------

      Identity card #             :
                                     -------------------------------

      Contact                     :
                                     -------------------------------


(11)  We set out below our details for registration of the Subscription Shares:

      Name                                    :
                                                -----------------------------

      Place of Incorporation                  :
                                                -----------------------------

      Company Number/ID Number                :
                                                -----------------------------


                                       6
<PAGE>


      Registered/Residential Address          :
                                                -----------------------------
                                                -----------------------------
                                                -----------------------------

      Correspondence Address                  :
                                                -----------------------------
                                                -----------------------------
                                                -----------------------------



We  fully  understand  that our  personal  data set out  above  and any  further
personal  data  relating to ourselves  may be submitted to the SEC and OTCBB and
hereby confirm that the data is true and accurate.

Yours faithfully,
For and behalf of



-----------------------



-----------------------
-----------------------

Director


Date:    September 21, 2005












                                       7